513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cabot reported fiscal fourth-quarter 2024 net sales of $1,001 million, up from $965 million a year earlier, and Adjusted EPS of $1.80, up from $1.65. GAAP diluted EPS fell to $2.43 from $4.10, and the company said its fourth-quarter results included a benefit from a lower operating tax rate. For fiscal 2025, Cabot expects Adjusted EPS of $7.40 to $7.80, compared with $7.06 in fiscal 2024.
Q4 net sales $1,001 million vs $965 million a year earlier; Q4 net income attributable to Cabot $137 million vs $234 million
Q4 Adjusted EPS $1.80 vs $1.65; GAAP diluted EPS $2.43 vs $4.10
Fiscal 2024 Adjusted EPS $7.06, up 31% from $5.38; fiscal 2025 Adjusted EPS outlook $7.40 to $7.80
Department of Energy selected Cabot for a $50 million award; final terms expected by January 2025; Investor Day set for December 4, 2024
For the quarter ended September 30, 2024, Franklin BSP Realty Trust reported GAAP net income of $30.2 million, or $0.30 per diluted share, compared with a $3.8 million loss in the prior quarter. Distributable Earnings, a non-GAAP measure the company says supports its dividend, was a loss of $4.0 million, or $(0.10) per share, down from $32.4 million in the second quarter. The GAAP improvement was offset by that drop, and the company declared a third-quarter common dividend of $0.355 per share.
GAAP net income of $30.2 million ($0.30 diluted EPS) for Q3 2024, versus a $3.8 million loss in Q2 2024
Distributable Earnings of $(4.0) million, or $(0.10) per share fully converted, versus $32.4 million, or $0.31, in Q2 2024
Declared third-quarter common dividend of $0.355 per share; GAAP dividend coverage 85%, Distributable Earnings coverage (28)%
Book value $15.24 per diluted share fully converted; $31.1 million remained under the $65 million buyback as of October 30, 2024
The Andersons reported third quarter 2024 net income attributable to the company of $27.4 million, or $0.80 per diluted share, up from $9.7 million, or $0.28, a year earlier. Sales and merchandising revenues fell to $2.62 billion from $3.64 billion, which the company attributed to lower commodity prices. Shareholders get higher profit on lower revenue, with a webcast on November 5, 2024 to discuss the outlook.
Net income attributable to the company was $27.4 million, or $0.80 per diluted share, versus $9.7 million, or $0.28, in Q3 2023.
Adjusted diluted EPS was $0.72, compared with $0.13 a year earlier; adjusted EBITDA was $97.4 million, versus $70.3 million.
Sales and merchandising revenues were $2.62 billion, down from $3.64 billion in Q3 2023.
Webcast to discuss results and outlook is set for Tuesday, November 5, 2024, at 11 a.m. Eastern Time.
Eversource Energy reported a third-quarter 2024 GAAP net loss of $118.1 million, or $0.33 per share, compared with earnings of $339.7 million, or $0.97 per share, a year earlier, due to losses on its offshore wind investments. Excluding those items, non-GAAP recurring earnings rose to $405.9 million, or $1.13 per share, and the company updated its 2024 non-GAAP EPS projection to $4.52 to $4.60 from $4.50 to $4.67. The results matter to shareholders because the GAAP loss reflects the completed exit from offshore wind, while the company reaffirmed 5% to 7% long-term EPS growth.
Q3 2024 GAAP loss of $118.1 million ($0.33 per share) vs. earnings of $339.7 million ($0.97) in Q3 2023; offshore wind losses totaled $524.0 million after tax year to date
Q3 2024 non-GAAP recurring EPS of $1.13 vs. $0.97 a year earlier; nine-month non-GAAP EPS of $3.56 vs. $3.38
2024 non-GAAP EPS projection updated to $4.52 to $4.60 from $4.50 to $4.67, citing higher interest expense; long-term EPS growth of 5% to 7% reaffirmed
Five-year capital plan through 2028 increased to $23.7 billion from $23.1 billion, reflecting Massachusetts Electric Sector Modernization Plan approval; conference call on November 5, 2024 at 9 a.m. Eastern
NETSTREIT reported third quarter 2024 results with AFFO per diluted share of $0.32, up from $0.31 a year earlier, and a net loss of $0.07 per diluted share, compared with net income of $0.06 a year earlier. The company maintained the midpoint of its 2024 AFFO per share guidance and narrowed the range to $1.26 to $1.27, while the quarter's net loss reflected $9.8 million in impairment provisions.
Total revenues were $41.4 million for the quarter, versus $34.0 million a year earlier; provisions for impairment were $9.8 million, versus $1.5 million.
Investments totaled $151.6 million at a 7.5% blended cash yield, which the company described as its highest quarterly investment activity in its history.
2024 AFFO per share guidance range updated to $1.26 to $1.27 from $1.25 to $1.28, with the midpoint maintained.
Quarterly dividend of $0.21 per share declared October 18, 2024, payable December 13, 2024, an annualized increase of $0.02 per share.
Voya Financial reported third-quarter 2024 results on Nov. 4, 2024. Net income available to common shareholders fell to $98 million, or $0.98 per diluted share, from $248 million, or $2.29, a year earlier, while adjusted operating earnings rose to $190 million, or $1.90 per diluted share, from $1.74. The board also authorized an additional $500 million of share repurchases, and the company said higher loss ratios in Stop Loss weighed on Health Solutions.
Net income available to common shareholders was $98 million, or $0.98 per diluted share, versus $248 million, or $2.29, in third-quarter 2023; the prior year included tax benefits and a Voya India revaluation gain.
Adjusted operating earnings were $190 million, or $1.90 per diluted share, versus $189 million, or $1.74, a year earlier.
Total revenues were $1,956 million versus $1,823 million in the prior-year quarter.
The board authorized an additional $500 million of share repurchases, and the company expects to return $0.8 billion of capital for full-year 2024.
Apple Hospitality REIT reported third-quarter 2024 results on November 4, 2024, with net income down 3.8% from a year earlier while Adjusted EBITDAre rose 5.7%. The company also lowered its full-year 2024 net income and Adjusted EBITDAre guidance midpoints slightly, so shareholders see mixed headline results and a modest guidance reduction.
Q3 2024 net income was $56.3 million, down 3.8% from $58.5 million; net income per share was $0.23, down from $0.26
Q3 2024 Adjusted EBITDAre rose 5.7% to $128.9 million, and MFFO rose 3.2% to $107.4 million
Nine-month net income was $184.2 million, up 17.6%, and Comparable Hotels RevPAR rose 0.8% in Q3 to $125.30
Versus the midpoint of prior guidance, 2024 net income is down $1 million and Adjusted EBITDAre is down $1.5 million; updated net income range is $204 million to $221 million
Douglas Emmett reported third-quarter 2024 revenue of $250.8 million, down 1.8% from a year earlier, mainly due to lower office occupancy. Net income attributable to common stockholders rose to $4.6 million, or $0.03 per diluted share, after a loss a year earlier, but FFO fell 3.8% to $86.0 million. The company increased its 2024 guidance, citing its third-quarter results and higher expectations for the fourth quarter.
Q3 2024 revenues: $250.8 million, down 1.8% year over year
Net income attributable to common stockholders: $4.6 million, or $0.03 per diluted share, versus a $13.4 million loss in Q3 2023
FFO: $86.0 million, or $0.43 per fully diluted share, down 3.8%
Raised 2024 guidance: diluted net income per share of $0.10 to $0.14; FFO per fully diluted share of $1.69 to $1.73
Century Aluminum reported third quarter 2024 results on November 4, 2024. Net income attributable to Century stockholders rose to $47.3 million from a $2.5 million loss in the second quarter, helped by $34.9 million of Inflation Reduction Act credits, while net sales fell to $539.1 million. The company expects fourth quarter adjusted EBITDA of $70 million to $80 million, below the $103.7 million reported for the third quarter, and Theresa Brainerd assumed the principal accounting officer role.
Net sales were $539.1 million, down from $560.8 million in the second quarter of 2024.
Net income attributable to Century stockholders was $47.3 million, compared with a loss of $2.5 million in the prior quarter.
Fourth quarter 2024 adjusted EBITDA is expected to range from $70 million to $80 million, versus $103.7 million in the third quarter.
Rob Hoffman stepped down as principal accounting officer and remains Chief Information Officer; Theresa Brainerd, Global Corporate Controller, assumed the role.
Lattice Semiconductor reported third-quarter 2024 revenue of $127.1 million, up 2.4% from the prior quarter but down 33.9% from a year earlier, with GAAP net income of $0.05 per diluted share. The company guided fourth-quarter 2024 revenue to $112 million to $122 million, and it took a one-time GAAP-only charge of $6.5 million tied to a 14% workforce reduction and a 14% cut in non-headcount operating expenses.
Q3 2024 revenue was $127.1 million, up 2.4% from Q2 2024 and down 33.9% from Q3 2023's $192.2 million.
GAAP net income was $0.05 per diluted share, versus $0.16 in Q2 2024 and $0.38 in Q3 2023; non-GAAP net income was $0.24 per diluted share.
Fourth-quarter 2024 guidance: revenue of $112 million to $122 million and non-GAAP net income of $0.15 to $0.23 per share.
Ford Tamer was appointed Chief Executive Officer and joined the Board; the company is also recording a $6.5 million one-time GAAP-only charge tied to a 14% workforce reduction.
Cirrus Logic reported fiscal second-quarter 2025 revenue of $541.9 million, up 13% from a year earlier, with GAAP diluted earnings per share of $1.83 versus $1.34 a year earlier. The company guided third-quarter revenue to $480 million to $540 million, which is down six percent sequentially and down 18 percent year over year at the midpoint, so shareholders face a weaker near-term sales outlook after a strong quarter.
Q2 FY25 revenue was $541.9 million, up 45% from Q1 FY25 and up 13% from Q2 FY24
GAAP diluted EPS was $1.83 and non-GAAP diluted EPS was $2.25, compared with $1.34 and $1.80 in Q2 FY24
Q3 FY25 revenue guidance is $480 million to $540 million, and GAAP gross margin is forecast at 51% to 53%
One customer contributed approximately 90% of total revenue in Q2 FY25
Alpha and Omega Semiconductor reported fiscal first-quarter 2025 revenue of $181.9 million, up 12.8% from the prior quarter but up only 0.7% from a year earlier, with a GAAP net loss of $2.5 million. For the fiscal second quarter ending December 31, 2024, the company expects revenue of approximately $170 million, plus or minus $10 million, which is below the current quarter and points to a sequential decline.
Q1 revenue was $181.9 million, up 12.8% from the prior quarter and 0.7% from the same quarter last year.
GAAP net loss was $2.5 million, or $0.09 per diluted share, compared with net income of $5.8 million a year earlier.
Non-GAAP diluted EPS was $0.21, compared with $0.33 in the same quarter last year.
Q2 guidance calls for revenue of about $170 million, plus or minus $10 million, and GAAP gross margin of 24%, plus or minus 1%.
Krystal Biotech reported third-quarter 2024 net product revenue of $83.8 million, up from $8.6 million a year earlier, driven by VYJUVEK sales. Net income fell to $27.2 million, or $0.91 per diluted share, from $80.7 million, or $2.79 per diluted share, a year earlier; that period included a $100 million gain on the sale of a priority review voucher, and this quarter included a $12.5 million litigation settlement charge. The company also set full-year 2024 non-GAAP R&D and SG&A expense guidance of $115 million to $125 million.
Q3 2024 net product revenue was $83.8 million versus $8.6 million in Q3 2023; gross margin for VYJUVEK was 92% for the quarter.
Q3 2024 net income was $27.2 million, or $0.91 per diluted share, compared with $80.7 million, or $2.79 per diluted share, in Q3 2023.
Q3 2024 included a $12.5 million litigation settlement expense and $100 million gain from a priority review voucher sale was recorded in Q3 2023.
Cash, cash equivalents and investments totaled $694.2 million as of September 30, 2024; full-year 2024 non-GAAP R&D and SG&A guidance is $115 million to $125 million.
Knife River reported third quarter 2024 revenue of $1.1 billion, up 1% from a year earlier, and net income of $148.1 million, also up 1%. Adjusted EBITDA fell 1% to $245.2 million, and the company narrowed its full-year 2024 revenue and adjusted EBITDA guidance. Shareholders get higher top-line and earnings figures for the quarter, but adjusted EBITDA slipped and the company has spent $129.3 million on six acquisitions since the start of the fourth quarter.
Q3 2024 revenue $1,105.3 million vs. $1,090.4 million; net income $148.1 million vs. $146.7 million
Diluted EPS $2.60 vs. $2.58 a year earlier; adjusted EBITDA $245.2 million vs. $247.5 million
Full-year 2024 guidance: revenue $2.85 billion to $2.95 billion; adjusted EBITDA $445 million to $465 million
Through Nov. 2, 2024, the company deployed $129.3 million on six acquisitions, including Albina Asphalt purchased Nov. 2
Marriott reported third quarter 2024 results with reported diluted EPS of $2.07, down from $2.51 a year earlier, and reported net income of $584 million, down from $752 million. Adjusted diluted EPS rose to $2.26 from $2.11, and worldwide RevPAR increased 3.0 percent, so shareholders see a mixed picture depending on which measure they follow. The company also set full-year 2024 adjusted diluted EPS guidance of $9.19 to $9.27 and expects to return about $4.4 billion to shareholders in 2024.
Reported diluted EPS $2.07 vs. $2.51 a year earlier; reported net income $584 million vs. $752 million
Adjusted diluted EPS $2.26 vs. $2.11; adjusted net income $638 million vs. $634 million; adjusted EBITDA $1,229 million vs. $1,142 million
Full-year 2024 adjusted diluted EPS outlook $9.19 to $9.27; fourth-quarter outlook $2.31 to $2.39
Initiative expected to yield $80 million to $90 million of annual G&A cost reductions beginning in 2025
TG Therapeutics reported third quarter 2024 results and raised its full-year 2024 U.S. BRIUMVI net product revenue target to $300 million to $305 million, up from $290 million to $300 million. Product sales are growing quickly, but total revenue and net income fell sharply from the prior-year period, which included a large license payment.
Q3 2024 U.S. BRIUMVI net product revenue was $83.3 million, about 15% above the prior quarter and over 230% above Q3 2023.
Full-year 2024 U.S. BRIUMVI net revenue target raised to $300 million to $305 million from $290 million to $300 million.
Q3 2024 net income was $3.9 million, compared with $113.9 million in Q3 2023, which included license revenue of $140.7 million.
Cash, cash equivalents and investment securities were $341.0 million as of September 30, 2024.
Entegris reported third-quarter 2024 results on November 4, 2024. Reported net sales fell 9% from the prior year to $808 million, while sales excluding divestitures rose 7%, and CEO Bertrand Loy said sales came in below expectations. GAAP diluted EPS rose to $0.51 from $0.22, and non-GAAP diluted EPS rose to $0.77 from $0.68, and the company guided fourth-quarter sales to $810 million to $840 million.
Q3 2024 net sales were $807.7 million, down from $888.2 million a year earlier; sales excluding divestitures grew 7%.
GAAP diluted EPS was $0.51 versus $0.22; non-GAAP diluted EPS was $0.77 versus $0.68.
Q4 2024 guidance: sales of $810 million to $840 million and non-GAAP diluted EPS of $0.75 to $0.82.
The company realigned into two reportable segments on October 30, 2024, combining MC and AMH.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.